University Hospital, Basel, Switzerland
Clinical trials sponsored by University Hospital, Basel, Switzerland, explained in plain language.
-
Villagers vs. diabetes: can a phone app and local helpers beat the clinic?
Disease control OngoingThis study is testing a new way to manage type 2 diabetes in remote villages in Lesotho. It will see if local, trained community health workers, supported by a smartphone app, can safely provide basic diabetes care and medication. This is being compared to the usual method of sen…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Local villagers armed with smartphones take on silent killer
Disease control OngoingThis study tests a new way to manage high blood pressure in rural Lesotho. It trains local village health workers to screen, diagnose, and prescribe basic medication using a smartphone app, all within their communities. The goal is to see if this local care is as good as or bette…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Could common drugs stop dangerous sugar crashes?
Disease control TerminatedThis study aimed to see if two existing drugs could help people with prediabetes who experience dangerous drops in blood sugar after eating. It planned to test empagliflozin (a diabetes drug) and anakinra (an anti-inflammatory drug) against a placebo. The goal was to reduce the n…
Phase: PHASE2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test supercharged immune cells to fight tough skin cancer
Disease control OngoingThis is an early safety study for people with advanced melanoma that has stopped responding to standard treatments. Doctors will collect a patient's own tumor-fighting immune cells, grow them in a lab, and then infuse them back into the patient along with a new drug (ANV419) desi…
Phase: PHASE1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
New scanner could cut critical minutes off stroke diagnosis
Diagnosis OngoingThis study is testing a new type of CT scanner designed to be used right in the operating room. The goal is to see if it can tell the difference between a stroke caused by a clot and one caused by bleeding as accurately as the standard hospital scanner. If it works, doctors could…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Mar 30, 2026 14:32 UTC
-
New scan could replace invasive test for Cushing's disease
Diagnosis ENROLLING_BY_INVITATIONThis study aims to see if a new type of brain scan (called [18F]FET PET-MRI) can be as good as, or better than, the current invasive standard test at finding the exact source of Cushing's disease. It will involve 43 adults with confirmed Cushing's disease who need the invasive te…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Mar 20, 2026 14:48 UTC
-
Race against time: study tests 1-Hour vs. 3-Hour heart attack test
Diagnosis OngoingThis large study aims to see if a faster blood test can safely and accurately diagnose heart attacks. It compares a new 1-hour testing method against the current standard 3-hour method in emergency room patients with chest pain. The goal is to see if the faster test works just as…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Mar 12, 2026 13:52 UTC
-
Can time with animals help kids cope with stress and autism?
Symptom relief OngoingThis study is testing whether a group training program that involves interacting with animals can help children build resilience. It is for kids aged 2-4 or 8-12 who have experienced stressful life events or have an autism diagnosis. Participants will attend 12 outdoor sessions f…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated Apr 01, 2026 14:43 UTC
-
Patients and doctors share Real-World struggles with pituitary tumor care
Knowledge-focused OngoingThis survey aims to understand the real-world experiences of patients and doctors managing prolactinomas, a common type of pituitary tumor. It asks about treatment side effects, preferences, and quality of life to identify challenges and improve future care. The goal is to gather…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC
-
Blood test trial aims to track cancer without invasive biopsies
Knowledge-focused OngoingThis study is testing how well a blood test, called a liquid biopsy, can be used to monitor cancer during a patient's regular care. It involves 159 adults with advanced solid tumors who are starting their first treatment. Researchers will see if the blood test results help guide …
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC
-
Swiss researchers probe long COVID mysteries with App-Based therapy trial
Knowledge-focused OngoingThis Swiss study aims to better understand what causes Long COVID by observing 120 patients over time. As part of the research, some participants can try a 12-week program of breathing, relaxation, and fatigue management exercises delivered through a smartphone app to see if it h…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:52 UTC